EMA raises NDMA impurity concerns in diabetes drug made by Hetero; shareholder revolt rocks Bayer
This week, there is news on EMA telling companies using certain reagents to make diabetes drug — pioglitazone &mdash...
Impressions : 3992
GSK chairman to step down ahead of split; Novartis’ CEO shares updates on digital healthcare
This week, Phispers brings you news from two Indian companies — Sun Pharmaceuticals and Aurobindo Pharma.
While Sun is ...
Impressions : 3025
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.